In another clinical trial, 18F-F-AraG PET will be used to detect T cell activation in non-small cell lung cancer patients undergoing PD-1/PD-L1-directed therapy (NCT04186988). The gene discussed is CD274; the disease is non-small cell lung carcinoma.